Genetic Signatures Limited is a molecular diagnostics company. The Company is engaged in the research and commercialization of identifying individual genetic signature to identify diseases and disabilities, and the sale of associated products into diagnostic and research market place. It is focused on the development and commercialization of its platform technology, 3Base. The Company has a suite of polymerase chain reaction (PCR)-based products for the detection of infectious diseases under the EasyScreen brand. Its product portfolio includes EasyScreen detection kits and MethylEasy research kits. The Company's 3base technology forms the basis of its EasyScreen Pathogen Detection Kits. Its EasyScreen products provide hospital and pathology laboratories with the molecular tools to screen for an array of infectious pathogens. Its MethylEasy research kits include Methyl Easy Xceed, which is a bisulfite modification research kit for the detection of methylation patterns in genes.